NO892125L - Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler. - Google Patents

Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler.

Info

Publication number
NO892125L
NO892125L NO89892125A NO892125A NO892125L NO 892125 L NO892125 L NO 892125L NO 89892125 A NO89892125 A NO 89892125A NO 892125 A NO892125 A NO 892125A NO 892125 L NO892125 L NO 892125L
Authority
NO
Norway
Prior art keywords
angiotensin
conversible
pharmaceuticals
potassium channel
enzyme inhibitors
Prior art date
Application number
NO89892125A
Other languages
English (en)
Other versions
NO180773B (no
NO892125D0 (no
NO180773C (no
Inventor
Reinhard Becker
Rainer Henning
Hansjoerg Urbach
Volker Tetz
Heinrich Christian Englert
Dieter Mania
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO892125D0 publication Critical patent/NO892125D0/no
Publication of NO892125L publication Critical patent/NO892125L/no
Publication of NO180773B publication Critical patent/NO180773B/no
Publication of NO180773C publication Critical patent/NO180773C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02K—DYNAMO-ELECTRIC MACHINES
    • H02K29/00—Motors or generators having non-mechanical commutating devices, e.g. discharge tubes or semiconductor devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Power Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO892125A 1988-05-28 1989-05-26 Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende en kombinasjon av angiotensin-omvandlende-enzymhemmer med kaliumkanal-modulator NO180773C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3818245A DE3818245A1 (de) 1988-05-28 1988-05-28 Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln

Publications (4)

Publication Number Publication Date
NO892125D0 NO892125D0 (no) 1989-05-26
NO892125L true NO892125L (no) 1989-11-29
NO180773B NO180773B (no) 1997-03-10
NO180773C NO180773C (no) 1997-06-18

Family

ID=6355378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892125A NO180773C (no) 1988-05-28 1989-05-26 Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende en kombinasjon av angiotensin-omvandlende-enzymhemmer med kaliumkanal-modulator

Country Status (18)

Country Link
US (1) US4975453A (no)
EP (1) EP0344572B1 (no)
JP (1) JPH0219326A (no)
KR (1) KR900018139A (no)
AT (1) ATE98130T1 (no)
AU (1) AU623397B2 (no)
CA (1) CA1332350C (no)
DE (2) DE3818245A1 (no)
DK (1) DK258889A (no)
ES (1) ES2061787T3 (no)
HU (1) HU205714B (no)
IE (1) IE63328B1 (no)
IL (1) IL90414A (no)
NO (1) NO180773C (no)
NZ (1) NZ229311A (no)
PH (1) PH26420A (no)
PT (1) PT90661B (no)
ZA (1) ZA894013B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684553B1 (fr) * 1991-12-10 1995-04-07 Bioprojet Soc Civ Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.
TW244350B (no) * 1991-12-14 1995-04-01 Hoechst Ag
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
DK1216038T3 (da) * 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
EP1240147A1 (en) * 1999-12-21 2002-09-18 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6620849B2 (en) 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
KR100591857B1 (ko) * 2004-06-04 2006-06-23 한국유나이티드제약 주식회사 안정성이 개선된 라미프릴 함유 약제학적 조성물
RU2007120821A (ru) * 2004-11-05 2008-12-10 Кинг Фармасьютикалз Рисерч Энд Дивелопмент Стабилизированные композиции рамиприла и способы получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
DE3364734D1 (en) * 1982-10-19 1986-08-28 Beecham Group Plc Novel chromans and chromenes
GB8308062D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
DE3410732A1 (de) * 1984-03-23 1985-09-26 Hoechst Ag, 6230 Frankfurt Methode zur behandlung des glaukoms
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3536687A1 (de) * 1985-10-15 1987-04-16 Hoechst Ag Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
DE3629060A1 (de) * 1986-08-27 1988-03-03 Bayer Ag Kombination von positiv inotrop wirkenden dihydropyridinen mit ace-hemmern, sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
NL8702502A (nl) * 1986-11-03 1988-06-01 Sandoz Ag Farmaceutisch preparaat voor toepassing tegen hypertensie en congestieve cardiale insufficientie.
ATE71535T1 (de) * 1986-12-06 1992-02-15 Beecham Group Plc Pharmazeutische zubereitungen.

Also Published As

Publication number Publication date
DK258889A (da) 1989-11-29
ES2061787T3 (es) 1994-12-16
HU205714B (en) 1992-06-29
IE891770L (en) 1989-11-28
DE3818245A1 (de) 1989-12-07
EP0344572A3 (de) 1991-01-16
PH26420A (en) 1992-07-15
ATE98130T1 (de) 1993-12-15
IL90414A0 (en) 1990-01-18
DK258889D0 (da) 1989-05-26
DE58906338D1 (de) 1994-01-20
PT90661A (pt) 1989-11-30
PT90661B (pt) 1994-10-31
IE63328B1 (en) 1995-04-19
NO180773B (no) 1997-03-10
JPH0219326A (ja) 1990-01-23
CA1332350C (en) 1994-10-11
ZA894013B (en) 1990-02-28
KR900018139A (ko) 1990-12-20
EP0344572A2 (de) 1989-12-06
NO892125D0 (no) 1989-05-26
IL90414A (en) 1993-07-08
NZ229311A (en) 1992-05-26
AU3522089A (en) 1989-11-30
AU623397B2 (en) 1992-05-14
NO180773C (no) 1997-06-18
HUT52370A (en) 1990-07-28
US4975453A (en) 1990-12-04
EP0344572B1 (de) 1993-12-08

Similar Documents

Publication Publication Date Title
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK540986A (da) 2-substitueret-(2-substitueret amino)-n-arylalkyl-3-(indol-3-yl)propanamider, fremgangsmaade til deres fremstilling samt deres anvendelse
NO892125D0 (no) Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler.
NO871602D0 (no) 1-hydroksy-2-pyridoner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem samt ved fremstillingen av 1-hydroksy-2-pyridoner dannede mellomprodukter.
DK354188D0 (da) Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen
DK303688A (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO860907L (no) Heterocykliske sulfider og deres anvendelse som immunmodulatorer.
ATE417926T1 (de) Zusammensetzungen zur modulierung der länge von telomeren
DK393788D0 (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK450086D0 (da) 12- og 13-bromergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
DK449986A (da) 12- og 13-substituerede ergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
FI960839A0 (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
DK440688D0 (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK225189A (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK144989A (da) Disubstituerede pyrroler, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK134083D0 (da) 7-alfa-aminoacyl-3-chlorcephalosporiner, fremgangsmade til deres fremstilling samt deres anvendelse som laegemidler
DK321387D0 (da) Cytorhodin s-derivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK234989A (da) Aranosin, mikrobiologisk fremgangsmaade til fremstilling deraf, samt dets anvendelse som antibiotikum
DK264788D0 (da) Azolyl-tetrahydrofuran-2-yliden-methaner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK73487D0 (da) Antibiotika af streptogramin-type, mikrobiologisk fremgangsmaade til fremstilling og deres anvendelse som laegemidler og fodertilsaetningsmidler
DK342587D0 (da) Antibiotika, laegemidler indeholdende disse samt mikroorganisme til anvendelse ved deres fremstilling
ES2016857B3 (es) Derivados de 4 - feniltiazol.
NO894593L (no) Fremgangsmaate for fremstilling av renin-hemmende dipeptider, midler som inneholder disse og deres anvendelse.
NO911580D0 (no) 2-aminokarboksylsyrer og deres derivater, fremgangsmaate for fremstilling av disse og deres anvendelse som medikamenter.